Fortis, S.P.; Batsaki, P.; Stokidis, S.; Moschandreou, D.; Grouzi, E.; Baxevanis, C.N.; Gritzapis, A.D.; Goulielmaki, M.
A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate Cancer. Cancers 2023, 15, 3697.
https://doi.org/10.3390/cancers15143697
AMA Style
Fortis SP, Batsaki P, Stokidis S, Moschandreou D, Grouzi E, Baxevanis CN, Gritzapis AD, Goulielmaki M.
A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate Cancer. Cancers. 2023; 15(14):3697.
https://doi.org/10.3390/cancers15143697
Chicago/Turabian Style
Fortis, Sotirios P., Panagiota Batsaki, Savvas Stokidis, Dimitra Moschandreou, Elisavet Grouzi, Constantin N. Baxevanis, Angelos D. Gritzapis, and Maria Goulielmaki.
2023. "A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate Cancer" Cancers 15, no. 14: 3697.
https://doi.org/10.3390/cancers15143697
APA Style
Fortis, S. P., Batsaki, P., Stokidis, S., Moschandreou, D., Grouzi, E., Baxevanis, C. N., Gritzapis, A. D., & Goulielmaki, M.
(2023). A Blood-Based Immune Gene Signature with Prognostic Significance in Localized Prostate Cancer. Cancers, 15(14), 3697.
https://doi.org/10.3390/cancers15143697